Single-valve hydroxyethyl starch 130/0.4 sodium chloride injection

[Specification] 500ml

[Indications] Hydroxyethyl starch 130/0.4 in sodium chloride 0.9% solution is a plasma volume substitute for the treatment of hypovolaemia due to acute blood loss when crystalloids alone are not considered sufficient, subject to the applicable national marketing authorisation and product-specific prescribing information.

[Usage and dosage] Administer by intravenous infusion only when use is permitted by the applicable product authorisation. Use the lowest effective dose for the shortest possible duration, with continuous haemodynamic monitoring. Treatment should be restricted to the initial phase of volume resuscitation and should not exceed 24 hours. The maximum dose must follow the approved product-specific prescribing information. Do not use in patients with sepsis, critical illness, renal impairment or severe coagulopathy where these are listed as contraindications in the applicable label.